Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) is pleased to announce that Eurofins MWG Operon, an Ebersberg, Germany-based company, has officially become a Certified Service Provider (CSP) for NimbleGen Sequence Capture.
A consortium funded in frame of the German Plant Genome Program "GABI" has selected Eurofins MWG Operon as partner for sequencing and assembling of gene-rich parts of the barley genome. The project is carried out by multiplex sequencing of pools of BAC clones with Roche GS FLX / 454 technology and customised software solutions.
MWG Biotech, European market leader in genome sequencing and leading expert in next generation sequencing is further expanding its capacities in order to meet the demands of a steadily increasing number of sequencing customers across Europe.
Operon Biotechnologies, Eurofins MWG and Eurofins Medigenomix - all part of the Eurofins Genomics network - announced today that they have agreed to work together in order to create a new worldwide leader in the competitive custom oligonucleotide market.
MWG Biotech AG / Eurofins Medigenomix GmbH have successfully upgraded their Genome Sequencer 20 from Roche to the next generation Genome Sequencer FLX system.
Eurofins Medigenomix GmbH / MWG Biotech AG have finalised a genome sequencing project with Wacker Chemie AG for the analysis of the genetic differences between WACKER’s proprietary industrial protein production E. coli strain and its corresponding parental strain.
